News

CDMO's North Carolina development adds over 3,700 square feet worth of manufacturing space, equipment

Among focal points, New Jersey location will support clinical research, pharmacovigilance

Supply will start to become available in Q4 of this year, pending approval by EMA

CDMO says BFS capacity can now reach over 2 billion units yearly

WuXi STA will take reigns of the operations, as CDMO expands

Sector is expected to be driven by a rise in drug development and regulatory approvals for advanced therapies

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Guidance supports cross-industry collaboration for improved interoperability

Partnership to focus on gains for clinical development and commercialization through patient data curation and real-world data

Baltimore facility production was stopped after FDA flagged millions of contaminated doses

Private equity companies see the sector as having a valuable ROI, according to study

Pharmacy discount card company and e-commerce specialist team up on new Rx-med procedures channel

The latest people news happenings over the past month

German drugmaker also plans to set up manufacturing facilities in Africa

Deal for antibody developer expected to be largest ever for scientific instrument maker

In-house center eliminates the need for a contract manufacturer, company says

Acquisition is centered on market access and patient advocacy

European Commission to determine if Spikevax will receive emergency approval for children aged 12 to 17

Report notes that companies particularly look to vendor support for technologies such as 5G, IoT, and blockchain

3PL company's QuickSTAT site manages cell and gene therapies, vaccine storage, among other roles

Per agreement, facility will be producing over 100 million doses annually for use in African Union

Robotic filling and capping equipment to be installed in NIBRT’s global bioprocessing training and research center

Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Open-to-the-public workshops begin on July 28

Aims to grow its digital clinical trial offerings internationally

Track-and-trace agreement will focus on combating product counterfeiting

Will produce plasmid DNA-based therapies, mRNA vaccine materials